CAR T cells: The future is already present
Med Clin (Barc). 2019 Apr 5;152(7):281-286.
doi: 10.1016/j.medcli.2018.08.015.
Epub 2018 Nov 2.
[Article in
English,
Spanish]
Affiliations
- 1 Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, Nueva York (NY), Estados Unidos; Departamento de Enfermedades Hematológicas y Transplante de Médula Ósea, Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, España. Electronic address: [email protected].
- 2 Departamento de Enfermedades Hematológicas y Transplante de Médula Ósea, Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, España; Departamento de Hematología, Hospital Universitario Marqués de Valdecilla, Santander, España.
- 3 Departamento de Hematología, Hospital Clinic, Universidad de Barcelona; Institut d'investigacions Biomèdiques August Pi i Sunyer e Instituto de Investigación Josep Carreras, Barcelona, España.
- 4 Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, Nueva York (NY), Estados Unidos; Weill Cornell Medical College, Nueva York (NY), Estados Unidos. Electronic address: [email protected].
No abstract available
MeSH terms
-
Accreditation
-
Antigens, CD19 / therapeutic use
-
Biological Products
-
Hematopoietic Stem Cell Transplantation
-
Hospital Units / organization & administration
-
Humans
-
Immunotherapy, Adoptive / adverse effects
-
Immunotherapy, Adoptive / methods*
-
Lymphoma, Non-Hodgkin / therapy
-
Patient Care Team / organization & administration
-
Patient Selection
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
-
Receptors, Antigen, T-Cell / therapeutic use
-
Receptors, Chimeric Antigen / administration & dosage
-
Receptors, Chimeric Antigen / therapeutic use*
Substances
-
Antigens, CD19
-
Biological Products
-
Receptors, Antigen, T-Cell
-
Receptors, Chimeric Antigen
-
tisagenlecleucel
-
axicabtagene ciloleucel